TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76 | +300.0% | 10,900 | +1111.1% | 0.01% | +166.7% |
| Q2 2023 | $19 | +171.4% | 900 | +50.0% | 0.00% | +200.0% |
| Q1 2023 | $7 | -80.6% | 600 | -98.7% | 0.00% | -50.0% |
| Q4 2022 | $36 | -98.8% | 45,700 | +6428.6% | 0.00% | – |
| Q3 2022 | $3,000 | -62.5% | 700 | -88.1% | 0.00% | – |
| Q2 2022 | $8,000 | -92.9% | 5,900 | -86.5% | 0.00% | -100.0% |
| Q1 2022 | $112,000 | +20.4% | 43,837 | +76.6% | 0.01% | +50.0% |
| Q4 2021 | $93,000 | -69.9% | 24,820 | -34.6% | 0.00% | -71.4% |
| Q3 2021 | $309,000 | +173.5% | 37,940 | +254.6% | 0.01% | +133.3% |
| Q2 2021 | $113,000 | +264.5% | 10,700 | +214.7% | 0.01% | +200.0% |
| Q1 2021 | $31,000 | -73.0% | 3,400 | -75.3% | 0.00% | -66.7% |
| Q4 2020 | $115,000 | +400.0% | 13,749 | +85.8% | 0.01% | +200.0% |
| Q3 2020 | $23,000 | -84.1% | 7,400 | -51.0% | 0.00% | -77.8% |
| Q2 2020 | $145,000 | – | 15,100 | +202.0% | 0.01% | – |
| Q1 2020 | $0 | -100.0% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $9,000 | +800.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -87.5% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $8,000 | -20.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,000 | +66.7% | 5,000 | -52.1% | 0.00% | – |
| Q4 2018 | $6,000 | -90.9% | 10,444 | -40.5% | 0.00% | -100.0% |
| Q3 2018 | $66,000 | +1220.0% | 17,544 | +38.8% | 0.01% | – |
| Q2 2018 | $5,000 | -90.2% | 12,644 | -14.2% | 0.00% | -100.0% |
| Q1 2018 | $51,000 | +21.4% | 14,744 | -34.3% | 0.00% | +300.0% |
| Q4 2017 | $42,000 | -68.4% | 22,426 | -54.7% | 0.00% | -80.0% |
| Q3 2017 | $133,000 | +58.3% | 49,504 | -7.3% | 0.01% | +66.7% |
| Q2 2017 | $84,000 | -40.4% | 53,391 | -38.7% | 0.00% | -50.0% |
| Q1 2017 | $141,000 | +14000.0% | 87,120 | +21680.0% | 0.01% | – |
| Q4 2016 | $1,000 | -66.7% | 400 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 400 | -76.5% | 0.00% | – |
| Q2 2016 | $2,000 | -99.0% | 1,700 | -91.7% | 0.00% | -100.0% |
| Q1 2016 | $195,000 | +30.0% | 20,451 | -10.3% | 0.01% | +44.4% |
| Q4 2015 | $150,000 | – | 22,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |